Signa Vitae. 2024; 20(8): 13-20. doi: 10.22514/sv.2024.094
Original Research

Comparison of the Air-Q®sp versus the LMA® Supreme™ in patients undergoing laparoscopic gynecologic surgery: a single-blind, randomized controlled trial

Chan Noh1,2,, Seounghun Lee3,, Jiyong Lee1,2, Boohwi Hong1,2, Woosuk Chung1,2, Youngkwon Ko1,2, Yoon-Hee Kim1,2, Chahyun Oh1,2,*,, Sun Yeul Lee1,2,*,

1Department of Anesthesiology and Pain Medicine, Chungnam National University Hospital, 35015 Daejeon, Republic of Korea

2Department of Anesthesiology and Pain Medicine, College of Medicine, Chungnam National University, 35015 Daejeon, Republic of Korea

3Department of Anesthesiology and Pain Medicine, Chungnam National University Sejong Hospital, 30099 Sejong, Republic of Korea

*Corresponding Author(s): neoquack@cnuh.co.kr (Sun Yeul Lee); 5chahyun@cnuh.co.kr (Chahyun Oh)

† These authors contributed equally.

History Submitted: 10 January 2024 | Accepted: 05 March 2024 | Published: 08 August 2024
Copyright:  ©2024 The Author(s). Published by MRE Press.
This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).

Collapse table of contents

Abstract

Previous studies have reported the clinical utility of the LMA® Supreme™ (LMA Supreme) in laparoscopic surgery under general anesthesia, but there has been limited research on the effectiveness of the self-pressurized Air-Q® (Air-Q) in this clinical context. This study assessed the clinical performance of the Air-Q in laparoscopic gynecological surgeries by comparing its effectiveness, particularly in terms of oropharyngeal leak pressure (OLP), against that of the LMA Supreme. Fifty-two female patients (American Society of Anesthesiologists class I–II) scheduled for laparoscopic gynecologic surgery were randomly assigned to either the Air-Q group or the LMA Supreme group. The primary outcome was OLP, and secondary outcomes included the number of attempts required for device insertion, the time taken for insertion, difficulty of insertion, leakage rate, and complications associated with supraglottic airway device use. The Air-Q group exhibited a significantly lower OLP compared to the LMA Supreme group (19.5 ± 4.1 cmH2O vs. 23.2 ± 6.0 cmH2O, p = 0.011), with a mean difference of −3.8 cmH2O (95% confidence interval, −6.6 to −0.9 cmH2O). Analysis of secondary outcomes revealed no significant differences between the two groups. LMA Supreme could be preferred over Air-Q for airway management during general anesthesia in patients undergoing laparoscopic gynecologic surgery primarily due to its higher OLP. However, the Air-Q remains a viable alternative, exhibiting no significant differences in leakage rates compared to LMA Supreme.

Keywords:Supraglottic airway device;Laryngeal mask airway;Airway management;General anesthesia;Laparoscopic surgery;Gynecologic surgery
PDF(2.94 MB)|EndNote (RIS)|BibTeX|RefMan|RefWorks

Cite this article

Chan Noh, Seounghun Lee, Jiyong Lee, Boohwi Hong, Woosuk Chung, Youngkwon Ko, Yoon-Hee Kim, Chahyun Oh, Sun Yeul Lee. Comparison of the Air-Q®sp versus the LMA® Supreme™ in patients undergoing laparoscopic gynecologic surgery: a single-blind, randomized controlled trial. Signa Vitae. 2024; 20(8): 13-20. doi: 10.22514/sv.2024.094

1. Introduction

Supraglottic airway devices (SADs) have proven to be a valuable alternative to endotracheal intubation for patients undergoing general anesthesia [1, 2, 3, 4, 5] as they provide safe and effective ventilation without the need for laryngoscopy, thereby reducing hemodynamic fluctuations and minimizing postoperative complications such as sore throat and hoarseness [6, 7]. While extensive evidence supports their safety and/or usefulness in various clinical scenarios [8, 9, 10, 11, 12, 13, 14], it is important to acknowledge the potential risk of aspiration, given that SADs do not offer complete airway protection [15]. This concern may be particularly relevant in certain situations, such as during laparoscopic surgery, where the presence of pneumoperitoneum could increase the risk of aspiration, prompting questions about the safety of SAD use [15, 16].

The LMA® Supreme™ (Teleflex Medical Europe Ltd, Westmeath, UK) is a second-generation SAD characterized by a preformed curved shaft that includes a dual lumen: a central lumen for digestive tract access and an oval-shaped airway lumen, along with an integrated bite block [17]. Several studies have confirmed its effectiveness and safety when used as a standalone SAD [8, 18], and it has been recommended as an appropriate airway management tool for laparoscopic surgery [19, 20].

The Air-Q®sp (self-pressurizing) (Mercury Medical, Clearwater, FL, USA) is a newer SAD device, distinguished by its self-pressurizing cuff. This cuff is designed to automatically adjust to changes in airway pressure, allowing it to conform to the unique pharyngeal and peri-glottic structures of the patient. It has been reported to be effective in general anesthesia [21], suggesting potential advantages over traditional SADs [22]. However, data on its utility in laparoscopic surgical settings, particularly in gynecological laparoscopy, remains scarce.

Herein, we designed this present study to evaluate the clinical performance of the Air-Q in gynecological laparoscopic procedures, particularly in regard to oropharyngeal leak pressure (OLP) in comparison to LMA Supreme.

2. Materials and methods

2.1 Study design and participants

This study is a single-blind, randomized trial comprising female patients aged between 19 and 70 years, classified as American Society of Anesthesiologists (ASA) class 1 or 2, who were scheduled for laparoscopic gynecologic surgery under general anesthesia. The surgical procedures encompassed hysterectomy, myomectomy, salpingectomy, ovarian cystectomy and oophorectomy. Exclusion criteria comprised patients on medication for cardiovascular diseases (except hypertension), those who were pregnant, had a diagnosis of gastroesophageal reflux disease, a body mass index (BMI) >35 kg/m2, or presented with conditions that could complicate airway management as identified during the preoperative physical examination, such as limited mouth opening, reduced head and neck mobility, a Mallampati score of 4, and micrognathia.

2.2 Anesthesia and airway management

Each patient was administered a 0.2 mg intramuscular injection of glycopyrrolate before entering the operating room. Subsequently, general anesthesia was initiated, accompanied by monitoring through electrocardiography, noninvasive blood pressure, pulse oximetry (SpO2), pulse rate, and processed electroencephalogram signals. The induction phase of anesthesia began with an intravenous administration of propofol at 1.5–2.0 mg/kg, followed by rocuronium at 0.6 mg/kg and remifentanil at 1.0 μg/kg. Upon verification of the absence of response to a jaw thrust maneuver, the patients were randomized to receive either Air-Q or LMA Supreme, in accordance with their group allocation (Fig. 1). Rocuronium was subsequently administered at an empirical rate of 10–20 mg/hr or as necessitated by clinical conditions.

Supraglottic airway devices used in this study. Panels (A) and 
(B) show the Air-Q®sp device (self-pressurizing) (Mercury 
Medical, Clearwater, FL, USA), and panels (C) and (D) display the 
LMA® Supreme™ device (Teleflex Medical Europe Ltd, 
Westmeath, UK).

Fig. 1.Supraglottic airway devices used in this study. Panels (A) and (B) show the Air-Q®sp device (self-pressurizing) (Mercury Medical, Clearwater, FL, USA), and panels (C) and (D) display the LMA® Supreme™ device (Teleflex Medical Europe Ltd, Westmeath, UK).

The insertion of all SADs was conducted in accordance with the manufacturer’s guidelines by an anesthesiologist experienced in SAD usage. Prior to the study, the anesthesiologist had successfully inserted the Air-Q and LMA Supreme devices more than 20 times each. Lidocaine gel was applied to the posterior surface of each SAD prior to insertion. The selection of SAD sizes was based on the manufacturers’ recommendations: for Air-Q, size 2.5 for individuals weighing 30–50 kg, size 3.5 for those between 50–70 kg, and size 4.5 for subjects weighing 70–100 kg. For LMA Supreme, size 3 was used for subjects weighing 30–50 kg, size 4 for those between 50–70 kg, and size 5 for individuals weighing 70–100 kg. As Air-Q has a self-inflating cuff, no manual inflation was required, whereas for LMA Supreme, a cuff pressure of 30 cmH2O was maintained. This pressure is within the optimal range, being lower than the maximum recommended pressure of 60 cmH2O [23] and higher than the minimum suggested pressure of approximately 12–13 cmH2O for a classic LMA [24].

Successful SAD insertion was determined by the generation of at least two rectangular capnogram waves and visible thoracoabdominal movement, indicating effective ventilation. If significant air leakage occurred or adequate ventilation could not be established, the SAD was immediately removed for reinsertion, and if there were two successive unsuccessful attempts at insertion, the protocol mandated switching to endotracheal intubation.

After successful airway management, anesthesia was maintained with desflurane (4–6 vol%) and remifentanil (0.05–0.2 μg/kg/min) and was adjusted accordingly to maintain an adequate anesthesia depth (bispectral index between 40 and 60) and to ensure blood pressure and pulse rate remained within ±20% of baseline values. Ventilation was maintained with an inspired oxygen fraction of 0.5, a respiratory rate of 10–20 breaths per minute, and a tidal volume of 6–8 mL/kg, targeting an end-tidal CO2 partial pressure of 35–40 mmHg without applying positive end-expiratory pressure. Upon CO2 insufflation into the abdominal cavity, the patient’s position was altered to a 15-degree Trendelenburg, and the intra-abdominal pressure was maintained at 12 mmHg.

2.3 Outcome measures

The primary outcome was OLP measured immediately following SAD insertion. It was determined by closing the adjustable pressure-limiting valve while setting the fresh gas flow rate at 3 L/min and recording the airway pressure at which equilibrium was reached or when an audible air leak was detected around the mouth [25], with the maximum pressure capped at 40 cmH2O. Trained physicians conducted the OLP measurement and used a stethoscope to check for any air leakage.

Secondary outcomes included the number of attempts required for SAD insertion, time taken for insertion, difficulty of insertion (rated on a scale from 1 to 4, where “1” indicates easy insertion without resistance; “2” denotes successful insertion on the first attempt but with resistance encountered; “3” reflects successful insertion on the second attempt; and “4” represents failure on the second attempt), rate of air leakage, and complications related to SAD use such as laryngeal spasm, sore throat, dysphagia and hoarseness. The leakage rate was assessed by calculating the ratio of leakage volume (the difference between inspired and expired tidal volumes) to the inspiratory volume, with data acquired from the anesthesia machine. To adjust for the expansion of gas due to increased temperature and humidification, the inspired tidal volume was multiplied by a factor of 1.12 for the leakage volume calculation [26]. Leakage rates were documented at the following intervals: (1) 10 minutes post-SAD insertion; (2–4) immediately, 15 and 25 minutes after pneumoperitoneum initiation; and (5) subsequent to CO2 removal. Additionally, the peak inspiratory pressure (PIP) at each aforementioned time point was recorded.

2.4 Randomization and blinding

The study participants were randomly assigned to groups using a computer-generated 1:1 random number table. Due to the distinctive features of the SADs, both the individuals performing the procedure and the researchers conducting intraoperative measurements were aware of the group assignments. Nonetheless, the patients and the evaluators assessing postoperative outcomes were blinded to the study allocation.

2.5 Sample size

The required sample size was calculated based on an assumed OLP of 20 ± 5 cmH2O in patients with LMA Supreme [8, 27]. To detect a 5 cmH2O (25%) difference in OLP between groups, with a risk of 5% type 1 error and 90% power, a minimum of 23 patients in each group was required, resulting in a total of 46 participants. To account for a potential 10% dropout rate, the total number of participants targeted for recruitment was increased to 52.

2.6 Statistical analysis

Continuous variables were analyzed using Student’s t-test or the Mann-Whitney U test, based on data normality assessed by the Shapiro-Wilk test, and the results are presented as mean ± standard deviation (SD) or median (first quartile, third quartile), accordingly. The effect size and 95% confidence interval (CI) for the primary outcome were computed and reported as the mean or median difference as appropriate. Categorical variables are expressed as counts (percentage) and assessed using the chi-square test or Fisher’s exact test. The group difference in repeated measurements were evaluated with linear mixed models. All statistical analyses were conducted using R software, version 4.2.2 (R Project for Statistical Computing, Vienna, Austria), and a two-tailed p-value < 0.05 was used to indicate statistical significance.

2.7 Post-hoc exploratory analysis

The difference between PIP and OLP was computed for each time point as PIP minus OLP. Pearson’s correlation coefficient was then calculated to assess the relationship between these differences (PIP − OLP) and the leakage rates at each corresponding time point.

3. Results

A total of 55 patients were initially assessed for eligibility, and 3 were excluded according to the inclusion criteria. The remaining 52 participants were randomized and underwent the assigned intervention. One patient in the LMA Supreme group necessitated endotracheal intubation for the maintenance of adequate ventilation during the surgery. This conversion occurred between the initial and the second measurement of leakage volume during pneumoperitoneum. There were no cases requiring unexpected conversion to open surgery (laparotomy). All patients who were allocated interventions were included in the final analysis (Fig. 2). The clinical characteristics of the included patients are summarized in Table 1.

Patient flow diagram. Note: One patient in the LMA Supreme 
group required endotracheal intubation due to the inability to maintain adequate 
ventilation intraoperatively. This conversion occurred after the initial 
measurement of leakage volume immediately after CO2 inflation and before the 
second measurement 15 minutes after CO2 inflation. All enrolled patients 
were included in the primary outcome analysis.

Fig. 2.Patient flow diagram. Note: One patient in the LMA Supreme group required endotracheal intubation due to the inability to maintain adequate ventilation intraoperatively. This conversion occurred after the initial measurement of leakage volume immediately after CO2 inflation and before the second measurement 15 minutes after CO2 inflation. All enrolled patients were included in the primary outcome analysis.

Table 1.Clinical characteristics stratified by group.
CharacteristicsAir-Q (n = 26)LMA Supreme (n = 26)
Age (yr)45.5 (36.0, 51.0)47.0 (36.0, 51.0)
Weight (kg)56.1 (50.0, 62.0)59.5 (54.3, 65.9)
Height (cm)159.3 ± 6.0158.9 ± 5.7
BMI (kg/m2)22.3 (19.2, 25.8)23.5 (21.8, 26.6)
ASA 28 (30.8)7 (26.9)
Surgery duration (min)99.0 (79.0, 140.0)96.0 (79.0, 124.0)
Values are presented as mean ± SD, median (IQR), or number (%). Abbreviations: BMI: body mass index; ASA: American Society of Anesthesiologists physical status.

The OLP was significantly lower in the Air-Q group than in the LMA Supreme group (19.5 ± 4.1 cmH2O vs. 23.2 ± 6.0 cmH2O, p = 0.011, Fig. 3), with a difference of mean of −3.8 cmH2O (95% CI, −6.6 to −0.9 cmH2O). Most SAD insertions were successful on the first attempt (100% vs. 92.3% in Air-Q and LMA Supreme group, p = 0.490), with none requiring more than two attempts. No significant differences were observed in insertion time and difficulties between the two groups (Table 2).

Oropharyngeal leak pressure (OLP) stratified by group.

Fig. 3.Oropharyngeal leak pressure (OLP) stratified by group.

Table 2.Secondary outcomes stratified by group.
OutcomesAir-Q (n = 26)LMA Supreme (n = 26)p
SAD insertion attempts
First26 (100.0)24 (92.3)0.490
Second0 (0.0)2 (7.7)
Third0 (0.0)0 (0.0)
Insertion time (sec)33.5 (26.0, 40.0)29.0 (24.0, 33.0)0.190
Insertion difficulty*
Grade 121 (80.8)22 (84.6)0.256
Grade 25 (19.2)2 (7.7)
Grade 30 (0.0)2 (7.7)
Grade 40 (0.0)0 (0.0)
Values are presented as median (1Q, 3Q) or number (%). *Rated on a scale of 1 to 4: “1”, easily inserted without resistance; “2”, success on the first attempt but with resistance; “3”, success on the second attempt; “4”, failure on the second attempt. SAD: Supraglottic airway device.

There were 4, 6 and 1 missing measurements of leakage volume and peak inspiratory pressure during the 15, 25-minute, and immediately after the end of pneumoperitoneum, respectively. Data analysis revealed no significant difference in leakage rates across the investigated time points (p = 0.167). Also, there was no significant difference in PIPs across time points (p = 0.099). The comparison of leakage rates and PIPs between the groups at each time point is shown in Table 3. Two patients in the Air-Q group and one in the LMA Supreme group reported sore throat in the post-anesthesia care unit, and none experienced laryngeal spasm, dysphagia or hoarseness.

Table 3.Leakage rates and peak inspiratory pressures stratified by group.
MeasurementsAir-Q (n = 26)LMA Supreme (n = 26)p*
Leakage rates (%)
10 mins after SAD insertion8.0 ± 5.19.1 ± 4.40.404
Right after PP8.4 ± 6.09.4 ± 4.70.530
15 mins after PP**4.8 (3.6, 7.0)9.0 (4.1, 11.4)0.100
25 mins after PP**4.9 (3.1, 8.1)6.5 (3.7, 11.7)0.332
Right after the end of PP*5.9 ± 5.28.2 ± 4.30.099
Peak inspiratory pressure (cmH2O)
10 mins after SAD insertion10.0 (8.0, 13.0)11.5 (9.0, 16.0)0.118
Right after PP14.9 ± 5.017.0 ± 5.40.158
15 mins after PP**15.0 (12.0, 19.0)18.0 (15.0, 22.0)0.089
25 mins after PP**15.9 ± 5.318.3 ± 4.30.098
Right after the end of PP**11.5 (10.0, 18.0)15.0 (12.0, 19.0)0.153
Values are presented as mean ± SD or median (1Q, 3Q). Leakage rate was determined by calculating the ratio of the leakage volume (the difference between the inspired and expired tidal volume) to the inspiratory volume. A factor of 1.12 was multiplied by the inspired tidal volume for the calculation of the leakage volume. *No overall significant difference across time points was observed, and unadjusted p values are provided. **There were 4, 6 and 1 missing measurements of leakage volume and peak inspiratory pressure during the 15, 25-minute, and immediately after the end of pneumoperitoneum, respectively. Abbreviations: SAD: supraglottic airway device; PP: pneumoperitoneum.

The results of the post-hoc exploratory analysis revealed significant positive correlations between PIP − OLP values and leakage rates at 10 minutes after SAD insertion and immediately after the initiation of pneumoperitoneum (Fig. 4). However, the significance of these correlations diminished over time with the emergence of several outliers.

Correlations between the differences between peak inspiratory 
pressure (PIP) and oropharyngeal leak pressure (OLP) and the leakage rates at 
different intraoperative time points. The positive correlations were significant 
at 10 minutes after SAD insertion and right after the initiation of 
pneumoperitoneum. Abbreviations: PP: pneumoperitoneum.

Fig. 4.Correlations between the differences between peak inspiratory pressure (PIP) and oropharyngeal leak pressure (OLP) and the leakage rates at different intraoperative time points. The positive correlations were significant at 10 minutes after SAD insertion and right after the initiation of pneumoperitoneum. Abbreviations: PP: pneumoperitoneum.

4. Discussion

This study revealed that the OLP of the LMA Supreme was higher than that of Air-Q. Since OLP is an essential metric for evaluating the performance and safety of SADs, this finding suggests that LMA Supreme may offer greater reliability and safety for laparoscopic gynecological surgeries. Nevertheless, the Air-Q remains an important alternative, as it showed comparable results to the LMA Supreme in terms of insertion attempts, insertion time, difficulty of insertion, leakage rate, and complications.

The primary outcome of this investigation is consistent with the inherent differences in cuff mechanisms between the two evaluated devices. The Air-Q utilizes a self-pressurizing cuff that automatically adjusts its pressure in response to the surrounding airway pressure, negating the need for manual inflation. In contrast, the LMA Supreme’s cuff requires manual inflation, with the achieved cuff pressure directly impacting the effectiveness of the peri-glottic seal. This relationship between cuff pressure and OLP was previously established in studies focusing on the LMA Supreme, indicating that higher manually set cuff pressures correlate with increased OLP [27]. Specifically, a study noted an OLP of 18 cmH2O at a cuff pressure of 40 cmH2O, with an increase to 25.6 cmH2O when the cuff pressure was elevated to 80 cmH2O. In our research, we utilized a cuff pressure of 30 cmH2O for the LMA Supreme, which is below the lower benchmark set in prior investigations. Nevertheless, it is reasonable to infer that the LMA Supreme’s cuff pressure during general anesthesia would be at least equivalent to, if not surpassing, that of the Air-Q’s. Despite employing a lower cuff pressure than that reported in earlier LMA Supreme studies [8, 27], our findings indicate an OLP within a comparable range, highlighting the efficacy of the LMA Supreme in maintaining a robust airway seal under these conditions.

The self-pressurizing mechanism of the Air-Q device is designed to automatically adjust cuff pressure, potentially minimizing risks of tissue ischemia or discomfort associated with over-pressurization [28]. Despite this theoretical advantage, existing literature has not conclusively shown that the Air-Q outperforms other SADs in reducing such complications [29, 30]. Our findings are consistent with these observations, suggesting no distinct advantage of the Air-Q in this aspect. However, it should be acknowledged that the overall low incidence of postoperative complications observed with SAD use in our study limits the ability to conduct meaningful comparative analyses. Additionally, the use of lidocaine gel as a lubricant could serve as a confounding variable, potentially influencing the outcome.

The exploratory analysis conducted in this study revealed important notable findings regarding the relationship between PIP − OLP and airway sealing efficiency. PIP − OLP reflects the margin by which the PIP exceeds the OLP. Essentially, OLP gauges the buffer against airway leakage that occurs when airway pressures rise above the seal’s integrity. A lower OLP suggests a greater risk of air leakage if airway pressures surpass this threshold (Fig. 4). However, the interpretation of this positive correlation should be cautiously interpreted due to its potential variability and the influence of outliers. The absence of significant correlations during later surgical stages may be attributable to occasional leakage incidents, likely related to factors such as surgical manipulations, fluctuations in intra-abdominal pressures, or the partial reversal of neuromuscular blockade, thereby highlighting the complexity of maintaining effective airway seals and the impact of dynamic surgical conditions on airway management.

Current evidence supports the suitability of SADs for laparoscopic surgery, with several studies confirming their clinical significance [7, 16, 19, 20, 31, 32, 33, 34]. Notably, a randomized trial comparing LMA Supreme with endotracheal intubation for laparoscopic gynecologic procedures found the former to be superior and advantageous in airway management duration and lower rates of postoperative pharyngolaryngeal complications [7]. Despite these benefits, the use of SADs is not without potential challenges in airway security [15]. This was evident in our study, where a participant assigned to the LMA Supreme group required an unexpected switch to endotracheal intubation. Such occurrences indicate the necessity for vigilance in cases that complicate airway management, including patient positioning that restricts access to the airway or procedures near the head and neck that may disrupt SAD placement. Thus, meticulous patient selection is important to avoid or manage incidences requiring emergent conversion to endotracheal intubation [35].

The study has several limitations worth noting. First, it only included patients classified as ASA class 1 or 2 and those with a relatively lean physique, which may limit the extrapolation of findings to individuals with reduced respiratory compliance or those presenting a difficult airway. Furthermore, the study design did not account for patient comorbidities such as a history of smoking or chronic pulmonary disease. While such conditions are uncommon in the patient population undergoing gynecologic surgery at our institution, this omission may affect the generalizability of the results to wider populations with these conditions. Second, the LMA Supreme group was subjected to a lower cuff pressure setting, potentially not reflecting those that might be observed under conditions of higher cuff pressures. Lastly, the inability to blind the clinician performing the SAD insertions to group assignment might introduce bias into subjective measures such as the number of insertion attempts, insertion time, and perceived difficulty of insertion. However, the primary outcome, largely determined by inherent patient characteristics and device specifications, is expected to be minimally influenced by this lack of blinding [25].

5. Conclusions

In conclusion, this study suggests LMA Supreme as a more suitable choice for airway management under general anesthesia in laparoscopic gynecologic procedures, mainly because of its superior OLP. Nevertheless, Air-Q remains a viable alternative, as it showed no significant differences in leakage rates compared to LMA Supreme.

Availability of data and materials

The data presented in this study are available on reasonable request from the corresponding author.

Author contributions

CN, SL, JL, YHK, CO and SYL—designed the research study. CN, JL, BH, WC and YK—performed the research. CO and BH—analyzed the data. CN, SL, JL and CO—wrote the manuscript. All authors read and approved the final manuscript.

Ethics approval and consent to participate

The study protocol was approved by the Chungnam National University Hospital Institutional Review Board (IRB CNUH 2016-08-007-002) and was registered prior to patient enrollment at cris.nih.go.kr (KCT0003904). Written consent was obtained from all patients before anesthesia after explaining the purposes and methodology of the study.

Acknowledgment

The authors thank In-Sun Kwon (Chungnam National University Hospital) for helping with the statistical analysis.

Funding

This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2020R1C1C1005423).

Conflict of interest

The authors declare no conflict of interest.

References

Karaaslan E, Akbas S, Ozkan AS, Colak C, Begec Z. A comparison of laryngeal mask airway-supreme and endotracheal tube use with respect to airway protection in patients undergoing septoplasty: a randomized, single-blind, controlled clinical trial. BMC Anesthesiology. 2021; 21: 5.

[Google Scholar]

Pang N, Pan F, Chen R, Zhang B, Yang Z, Guo M, et al. Laryngeal mask airway versus endotracheal intubation as general anesthesia airway managements for atrial fibrillation catheter ablation: a comparative analysis based on propensity score matching. To be published in Journal of Interventional Cardiac Electrophysiology. 2024. [Preprint].

[Google Scholar]

Dong W, Zhang W, Er J, Liu J, Han J. Comparison of laryngeal mask airway and endotracheal tube in general anesthesia in children. Experimental and Therapeutic Medicine. 2023; 26: 554.

[Google Scholar]

Yang LQ, Zhu L, Shi X, Miao CH, Yuan HB, et al. Postoperative pulmonary complications in older patients undergoing elective surgery with a supraglottic airway device or tracheal intubation. Anaesthesia. 2023; 78: 953–962.

[Google Scholar]

Akimaru S, Nakanishi T, Hasegawa T, Sobue K. Anesthetic management of inguinal hernia surgery using a second-generation supraglottic airway in a patient with trisomy 18: a case report. Cureus. 2023; 15: e45337.

[Google Scholar]

Gong Y, Xu X, Wang J, Che L, Wang W, Yi J. Laryngeal mask airway reduces incidence of post-operative sore throat after thyroid surgery compared with endotracheal tube: a single-blinded randomized controlled trial. BMC Anesthesiology. 2020; 20: 16.

[Google Scholar]

Abdi W, Amathieu R, Adhoum A, Poncelet C, Slavov V, Kamoun W, et al. Sparing the larynx during gynecological laparoscopy: a randomized trial comparing the LMA Supreme and the ETT. Acta Anaesthesiologica Scandinavica. 2010; 54: 141–146.

[Google Scholar]

Seet E, Rajeev S, Firoz T, Yousaf F, Wong J, Wong DT, et al. Safety and efficacy of laryngeal mask airway Supreme versus laryngeal mask airway ProSeal: a randomized controlled trial. European Journal of Anaesthesiology. 2010; 27: 602–607.

[Google Scholar]

Segond N, Bellier A, Duhem H, Sanchez C, Busi O, Deutsch S, et al. Supraglottic airway device to improve ventilation success and reduce pulmonary aspiration during cardio-pulmonary resuscitation by basic life support rescuers: a randomized cross-over human cadaver study. Prehospital Emergency Care. 2023; 27: 695–703.

[Google Scholar]

Forestell B, Ramsden S, Sharif S, Centofanti J, Al Lawati K, Fernando SM, et al. Supraglottic airway versus tracheal intubation for airway management in out-of-hospital cardiac arrest: a systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials. Critical Care Medicine. 2024; 52: e89–e99.

[Google Scholar]

Andresen ÅEL, Varild Lauritzen M, Kramer-Johansen J, Kristiansen T. Implementation and use of a supraglottic airway device in the management of out-of-hospital cardiac arrest by firefighter first responders—a prospective feasibility study. Resuscitation Plus. 2023; 16: 100480.

[Google Scholar]

Hofmeyr R, Lubbe D. How we do it: endoscopic tracheal dilatation technique using a supraglottic airway device and non-occlusive balloon. The Journal of Laryngology & Otology. 2023; 137: 219–221.

[Google Scholar]

Warren J, Wilhelm K, Gupta P, Kazan C. Use of i-Gel supraglottic airway in a simulated cardiac arrest resuscitation during boat rescue transport by Los Angeles County fire lifeguard division: a proof-of-concept study. Air Medical Journal. 2024; 43: 34–36.

[Google Scholar]

Cavallin F, Brombin L, Turati M, Sparaventi C, Doglioni N, Villani PE, et al. Laryngeal mask airway in neonatal stabilization and transport: a retrospective study. European Journal of Pediatrics. 2023; 182: 4069–4075.

[Google Scholar]

Keller C, Brimacombe J, Bittersohl J, Lirk P, von Goedecke A. Aspiration and the laryngeal mask airway: three cases and a review of the literature. British Journal of Anaesthesia. 2004; 93: 579–582.

[Google Scholar]

Beleña JM, Ochoa EJ, Núñez M, Gilsanz C, Vidal A. Role of laryngeal mask airway in laparoscopic cholecystectomy. World Journal of Gastrointestinal Surgery. 2015; 7: 319–325.

[Google Scholar]

van Zundert AAJ, Gatt SP, van Zundert TCRV, Hagberg CA, Pandit JJ. Supraglottic airway devices: present state and outlook for 2050. Anesthesia & Analgesia. 2024; 138: 337–349.

[Google Scholar]

Chen X, Jiao J, Cong X, Liu L, Wu X. A comparison of the performance of the I-gel™ vs. the LMA-S™ during anesthesia: a meta-analysis of randomized controlled trials. PLOS ONE. 2013; 8: e71910.

[Google Scholar]

Teoh WH, Lee KM, Suhitharan T, Yahaya Z, Teo MM, Sia ATH. Comparison of the LMA Supreme vs the i-gel™ in paralysed patients undergoing gynaecological laparoscopic surgery with controlled ventilation. Anaesthesia. 2010; 65: 1173–1179.

[Google Scholar]

Park SY, Rim JC, Kim H, Lee JH, Chung CJ. Comparison of i-gel® and LMA Supreme® during laparoscopic cholecystectomy. Korean Journal of Anesthesiology. 2015; 68: 455–461.

[Google Scholar]

Galgon RE, Schroeder KM, Han S, Andrei A, Joffe AM. The air-Q® intubating laryngeal airway vs the LMA-ProSealTM: a prospective, randomised trial of airway seal pressure. Anaesthesia. 2011; 66: 1093–1100.

[Google Scholar]

Ahn EJ, Choi GJ, Kang H, Baek CW, Jung YH, Woo YC, et al. Comparative efficacy of the Air-Q intubating laryngeal airway during general anesthesia in pediatric patients: a systematic review and meta-analysis. BioMed Research International. 2016; 2016: 6406391.

[Google Scholar]

Seet E, Yousaf F, Gupta S, Subramanyam R, Wong D, Chung F. Use of manometry for laryngeal mask airway reduces postoperative pharyngolaryngeal adverse events. Anesthesiology. 2010; 112: 652–657.

[Google Scholar]

Bae GE, Shin HW, Lim HH, Ju BJ, Jang YK. Predicting the optimal minimal cuff volume of the laryngeal mask airway from physical examination parameters. Anesthesia and Pain Medicine. 2017; 12: 381–387.

[Google Scholar]

Keller C, Brimacombe JR, Keller K, Morris R. Comparison of four methods for assessing airway sealing pressure with the laryngeal mask airway in adult patients. British Journal of Anaesthesia. 1999; 82: 286–287.

[Google Scholar]

Wallin M, Hedenstierna G. Tidal volumes: cold and dry or warm and humid, does it matter? Journal of Clinical Monitoring and Computing. 2020; 34: 871–873.

[Google Scholar]

Zhang L, Seet E, Mehta V, Subramanyam R, Ankichetty SP, Wong DT, et al. Oropharyngeal leak pressure with the laryngeal mask airway Supreme™ at different intracuff pressures: a randomized controlled trial. Canadian Journal of Anesthesia. 2011; 58: 624–629.

[Google Scholar]

Sotis CL, Jafari H, Solano JJ, Fishman I. Transient hypoglossal and lingual nerve injury following the use of I-gel supraglottic airway: a case report. Cureus. 2023; 15: e47509.

[Google Scholar]

Ha SH, Kim M, Suh J, Lee JS. Self-pressurized air-Q® intubating laryngeal airway versus the LMA® Classic™: a randomized clinical trial. Canadian Journal of Anesthesia. 2018; 65: 543–550.

[Google Scholar]

Lee JS, Kim D, Choi SH, Ha SH, Kim S, Kim M. Prospective, randomized comparison of the I-gel and the self-pressurized air-Q intubating laryngeal airway in elderly anesthetized patients. Anesthesia & Analgesia. 2020; 130: 480–487.

[Google Scholar]

Sun Y, Zhang M, Gao X, Gao Z, Zou T, Guo Y, et al. Effect of the new video laryngeal mask airway SaCoVLM on airway management in lateral laparoscopic urological surgery: a single center randomized controlled trial. Scientific Reports. 2024; 14: 2132.

[Google Scholar]

Bandyopadhyay A, Puri S, Ashok V. Supraglottic airway device versus tracheal tube for pediatric laparoscopic surgery—a systematic review and meta‐analysis. Pediatric Anesthesia. 2023; 33: 905–912.

[Google Scholar]

Bidaye S, Sommerville A, Straker T. When is it safe to use a supraglottic airway device? Advanced uses for SGA devices. Current Anesthesiology Reports. 2023; 13: 13–21.

[Google Scholar]

Lee JE, Kim HY, Lee KW, Kim GS. Second-generation supraglottic airway in laparoscopic donor nephrectomy. Scientific Reports. 2023; 13: 8406.

[Google Scholar]

Hartsuyker P, Kanczuk ME, Lawn D, Beg S, Mengistu TS, Hiskens M. The effect of clafss 3 obesity on the functionality of supraglottic airway devices: a historical cohort analysis with propensity score matching. Canadian Journal of Anesthesia. 2023; 70: 1744–1752.

[Google Scholar]